{"id":"https://openalex.org/W1483928064","doi":"https://doi.org/10.1128/aac.41.2.331","title":"Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro","display_name":"Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro","alternate_titles":[],"publication_year":1997,"publication_date":"1997-02-01","ids":{"openalex":"https://openalex.org/W1483928064","doi":"https://doi.org/10.1128/aac.41.2.331","mag":"1483928064","pmid":"https://pubmed.ncbi.nlm.nih.gov/9021188","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/163710"},"language":"en","primary_location":{"id":"doi:10.1128/aac.41.2.331","doi":"https://doi.org/10.1128/aac.41.2.331","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.41.2.331","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1483928064"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC163710/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058052462","display_name":"Sarah Piancastelli Franzot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129975664","display_name":"Albert Einstein College of Medicine","ror":"https://ror.org/05cf8a891","country_code":"US","type":"education","lineage":["https://openalex.org/I129975664","https://openalex.org/I4210112371"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S P Franzot","raw_affiliation_strings":["Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA","institution_ids":["https://openalex.org/I129975664"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077902719","display_name":"Arturo Casadevall","orcid":"https://orcid.org/0000-0002-9402-9167","observed_orcids":["https://orcid.org/0000-0002-9402-9167"]},"institutions":[{"id":"https://openalex.org/I129975664","display_name":"Albert Einstein College of Medicine","ror":"https://ror.org/05cf8a891","country_code":"US","type":"education","lineage":["https://openalex.org/I129975664","https://openalex.org/I4210112371"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A Casadevall","raw_affiliation_strings":["Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA","institution_ids":["https://openalex.org/I129975664"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I129975664"],"apc_list":null,"apc_paid":null,"fwci":5.788,"has_fulltext":false,"cited_by_count":129,"citation_normalized_percentile":{"value":0.96358797,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"41","issue":"2","first_page":"331","last_page":"336"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11037","display_name":"Fungal Infections and Studies","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11037","display_name":"Fungal Infections and Studies","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.024800000712275505,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12369","display_name":"Pneumocystis jirovecii pneumonia detection and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cryptococcus-neoformans","display_name":"Cryptococcus neoformans","score":0.9440000057220459},{"id":"https://openalex.org/keywords/amphotericin-b","display_name":"amphotericin B","score":0.9639999866485596},{"id":"https://openalex.org/keywords/fluconazole","display_name":"fluconazole","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-antifungal-therapy","display_name":"combination antifungal therapy","score":0.875},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.796999990940094},{"id":"https://openalex.org/keywords/fluconazole-resistance","display_name":"fluconazole resistance","score":0.7269999980926514},{"id":"https://openalex.org/keywords/cryptococcal-meningitis","display_name":"cryptococcal meningitis","score":0.9789999723434448},{"id":"https://openalex.org/keywords/fractional-inhibitory-concentration-index","display_name":"fractional inhibitory concentration index","score":0.8320000171661377},{"id":"https://openalex.org/keywords/antifungal-susceptibility","display_name":"antifungal susceptibility","score":0.7239999771118164}],"concepts":[{"id":"https://openalex.org/C2780651595","wikidata":"https://www.wikidata.org/wiki/Q411478","display_name":"Fluconazole","level":3,"score":0.9410514235496521},{"id":"https://openalex.org/C2779629538","wikidata":"https://www.wikidata.org/wiki/Q412223","display_name":"Amphotericin B","level":3,"score":0.9132896065711975},{"id":"https://openalex.org/C2777893358","wikidata":"https://www.wikidata.org/wiki/Q131924","display_name":"Cryptococcus neoformans","level":2,"score":0.8631929755210876},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.6304116249084473},{"id":"https://openalex.org/C2779413141","wikidata":"https://www.wikidata.org/wiki/Q1470140","display_name":"Cryptococcosis","level":2,"score":0.5080006718635559},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4563165605068207},{"id":"https://openalex.org/C176947019","wikidata":"https://www.wikidata.org/wiki/Q597889","display_name":"Minimum inhibitory concentration","level":3,"score":0.44554296135902405},{"id":"https://openalex.org/C2991737395","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal drug","level":3,"score":0.44084325432777405},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4262903332710266},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.3013817369937897},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.272523432970047}],"mesh":[{"descriptor_ui":"D000077336","descriptor_name":"Caspofungin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000666","descriptor_name":"Amphotericin B","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003455","descriptor_name":"Cryptococcus neoformans","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004352","descriptor_name":"Drug Resistance, Microbial","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010456","descriptor_name":"Peptides, Cyclic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015725","descriptor_name":"Fluconazole","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D054714","descriptor_name":"Echinocandins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055666","descriptor_name":"Lipopeptides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1128/aac.41.2.331","doi":"https://doi.org/10.1128/aac.41.2.331","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.41.2.331","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:163710","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC163710/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:9021188","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9021188","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.855.3654","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.855.3654","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://aac.asm.org/content/41/2/331.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:163710","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC163710/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1120484384","display_name":null,"funder_award_id":"R01-AI133774","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G2816534893","display_name":null,"funder_award_id":"RCI-AI13342","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1493245599","https://openalex.org/W1581962345","https://openalex.org/W1594591013","https://openalex.org/W1703812573","https://openalex.org/W1963653528","https://openalex.org/W1965411902","https://openalex.org/W1971219620","https://openalex.org/W2033684081","https://openalex.org/W2062254434","https://openalex.org/W2077879221","https://openalex.org/W2103320857","https://openalex.org/W2103769989","https://openalex.org/W2106052007","https://openalex.org/W2108782926","https://openalex.org/W2131076784","https://openalex.org/W2171508090","https://openalex.org/W2323947717","https://openalex.org/W3026406881"],"related_works":["https://openalex.org/W2143465524","https://openalex.org/W3045451485","https://openalex.org/W2131076784","https://openalex.org/W2138113288","https://openalex.org/W2401862829","https://openalex.org/W2143126475","https://openalex.org/W4311953569","https://openalex.org/W3120159520","https://openalex.org/W3213366173","https://openalex.org/W2166495761"],"abstract_inverted_index":{"Cryptococcus":[0],"neoformans":[1,56,61,85],"infections":[2],"in":[3,140,255,264],"patients":[4],"with":[5,16,75,180,207,232],"AIDS":[6],"are":[7],"often":[8],"incurable,":[9],"despite":[10],"aggressive":[11],"antifungal":[12,40],"therapy.":[13],"Combination":[14,205],"regimens":[15],"additive":[17,212],"or":[18,45,156,236,252],"synergistic":[19],"drugs":[20],"could":[21],"provide":[22],"additional":[23],"options":[24],"for":[25,130,185,227,262],"treating":[26],"cryptococcal":[27],"meningitis.":[28],"We":[29],"evaluated":[30],"the":[31,94,111,124,131,186,248],"efficacy":[32,249],"of":[33,50,70,73,97,113,116,143,154,174,178,230,240,250],"combination":[34,69,229,265],"therapies":[35],"using":[36,93],"L-743,872,":[37],"a":[38,162,259],"pneumocandin":[39,179],"drug,":[41],"and":[42,64,99,105,146,167,198,203,209,213,257],"amphotericin":[43,76,80,144,165,234,253],"B":[44,77,81,133,145,166,235,254],"fluconazole":[46,119,121,181,208,251],"against":[47,83,216,267],"18":[48],"strains":[49,160],"C.":[51,55,60,84,268],"neoformans,":[52,58],"including":[53,189],"11":[54],"var.":[57,62],"3":[59],"gattii,":[63],"4":[65],"fluconazole-resistant":[66,217],"isolates.":[67,176,218],"The":[68,238],"subinhibitory":[71,114],"concentrations":[72,115],"L-743,872":[74,117,168,210,231,245,263],"significantly":[78],"enhanced":[79,120],"activity":[82],"as":[86],"measured":[87],"by":[88],"turbidity":[89],"(antifungal":[90],"susceptibility":[91,163],"studies":[92,206],"National":[95],"Committee":[96],"Clinical":[98],"Laboratory":[100],"Standards":[101],"method),":[102],"quantitative":[103],"CFU,":[104],"tetrazolium":[106],"salt":[107],"reduction":[108],"assays.":[109],"Similarly,":[110],"addition":[112],"to":[118,164,172],"activity,":[122],"but":[123],"effect":[125],"was":[126,138,170],"less":[127],"dramatic":[128],"than":[129],"pneumocandin-amphotericin":[132],"combination.":[134],"A":[135],"marked":[136],"synergism":[137,190],"observed":[139,226],"all":[141],"combinations":[142],"L-743,":[147],"872":[148],"(fractional":[149],"inhibitory":[150],"concentration":[151],"index":[152],"[FIC]":[153],"<":[155,192,223],"=":[157,196],"0.5).":[158],"Fluconazole-resistant":[159],"showed":[161,211],"which":[169],"comparable":[171],"that":[173,244],"susceptible":[175],"Combinations":[177],"revealed":[182],"different":[183],"activities":[184,215],"various":[187],"strains,":[188],"(FIC":[191,195,200,222],"1.0),":[193,197],"additivity":[194],"autonomy":[199],"between":[201],"1.0":[202],"2.0).":[204],"autonomous":[214],"No":[219],"antagonistic":[220],"interactions":[221],"2.0)":[224],"were":[225],"any":[228],"either":[233],"fluconazole.":[237],"results":[239],"this":[241],"study":[242],"suggest":[243],"can":[246],"enhance":[247],"vitro":[256],"indicate":[258],"potential":[260],"role":[261],"therapy":[266],"neoformans.":[269]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1483928064","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
